SCHEMBL7040415

SCHEMBL7040415

CCc1cc(Nc2cc(=O)n(CCCC(=O)O)c(=O)[nH]2)ccc1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3470773 0.92 — —
SCHEMBL7260279 0.89 — —
SCHEMBL5935102 0.87 — —
SCHEMBL7040963 0.87 — —
SCHEMBL3470402 0.86 — —
SCHEMBL3471990 0.86 — —
SCHEMBL7039037 0.86 — —
SCHEMBL3471868 0.86 — —
SCHEMBL5940598 0.86 — —
SCHEMBL8153188 0.85 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030114445-A1 N3-substituted 6-anilinopyrimidines and methods to treat-Gram-positive bacterial and mycoplasmal infections NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2003-06-19 — — US disclosed
WO-2003011297-A1 N3-SUBSTITUTED 6-ANILINOPYRIMIDINES AND METHODS TO TREAT GRAM-POSITIVE BACTERIAL AND MYCOPLASMAL INFECTIONS UNIVERSITY OF MASSACHUSETTS (US) 2003-02-13 — — WO disclosed
WO-2003000665-A1 ANTIBACTERIAL URACIL DERIVATIVES BAYER AKTIENGESELLSCHAFT (DE) 2003-01-03 — — WO disclosed
Send feedback